Postoperative chemoradiotherapy versus postoperative chemotherapy for completely resected gastric cancer with D2 Lymphadenectomy: a meta-analysis.

Postoperative chemoradiotherapy versus postoperative chemotherapy for completely resected gastric cancer with D2 Lymphadenectomy: a meta-analysis.

BACKGROUND: Both chemoradiotherapy and chemotherapy are used in postoperative adjuvant therapy for resected gastric cancer. However, it is controversial whether chemoradiotherapy or chemotherapy is the optimal strategy for patients with gastric cancer after D2 lymphadenectomy. The present meta-analy...

Full description

Bibliographic Details
Main Authors:	Yuan-Yuan Huang, Qiong Yang, Si-Wei Zhou, Ying Wei, Yan-Xian Chen, De-Rong Xie, Bei Zhang
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2013-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC3715514?pdf=render

Similar Items

Correction: Postoperative Chemoradiotherapy versus Postoperative Chemotherapy for Completely Resected Gastric Cancer with D2 Lymphadenectomy: A Meta-Analysis
by: Yuan-Yuan Huang, et al.
Published: (2013-01-01)

Correction: Postoperative Chemoradiotherapy versus Postoperative Chemotherapy for Completely Resected Gastric Cancer with D2 Lymphadenectomy: A Meta-Analysis.
by: Yuan-Yuan Huang, et al.
Published: (2013-01-01)

Indirect Comparison Showed Survival Benefit from Adjuvant Chemoradiotherapy in Completely Resected Gastric Cancer with D2 Lymphadenectomy
by: Qiong Yang, et al.
Published: (2013-01-01)

Preoperative Chemoradiotherapy Versus Postoperative Chemoradiotherapy for Patients With Locally Advanced Gastric Cancer: A Retrospective Study Based on Propensity Score Analyses
by: Wang Yang, et al.
Published: (2020-10-01)

Tumor Microenvironment Status Predicts the Efficacy of Postoperative Chemotherapy or Radiochemotherapy in Resected Gastric Cancer
by: Ran Duan, et al.
Published: (2021-01-01)

Postoperative adjuvant chemotherapy versus chemoradiotherapy for node-positive esophageal squamous cell carcinoma: a propensity score-matched analysis
by: Qifeng Wang, et al.
Published: (2020-05-01)

Comparison of Perioperative Chemotherapy versus Postoperative Chemoradiotherapy for Operable Stomach Cancer: A Western Canadian Province Experience
by: Adnan Zaidi, et al.
Published: (2021-03-01)

Modified Weekly Cisplatin-Based Chemotherapy Is Acceptable in Postoperative Concurrent Chemoradiotherapy for Locally Advanced Head and Neck Cancer
by: Hsueh-Ju Lu, et al.
Published: (2015-01-01)

Neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy for patients with resectable gastric cancer (CRITICS)
by: van Grieken Nicole CT, et al.
Published: (2011-08-01)

Postoperative chemoradiotherapy is superior to postoperative chemotherapy alone in squamous cell lung cancer patients with limited N2 lymph node metastasis
by: Liyu Su, et al.
Published: (2019-10-01)

The effect of fibrin glue on the postoperative lymphatic leakage after D2-lymphadenectomy and gastrectomy in patients with gastric cancer
by: Habibollah Mahmoodzadeh, et al.
Published: (2021-03-01)

The watch-and-wait strategy versus surgical resection for rectal cancer patients with a clinical complete response after neoadjuvant chemoradiotherapy
by: Qiao-xuan Wang, et al.
Published: (2021-01-01)

The Postoperative Component of MAGIC Chemotherapy Is Associated with Improved Prognosis following Surgical Resection in Gastric and Gastrooesophageal Junction Adenocarcinomas
by: A. Mirza, et al.
Published: (2013-01-01)

Tumor-infiltrating CD8+ T cells combined with tumor-associated CD68+ macrophages predict postoperative prognosis and adjuvant chemotherapy benefit in resected gastric cancer
by: Jun Lu, et al.
Published: (2019-09-01)

The efficiency of D1(+) lymphadenectomy in signet ring cell carcinoma: comparison of postoperative early and late outcomes between standard lymphadenectomy and D1(+) lymphadenectomy
by: Şevket Barış Morkavuk, et al.
Published: (2021-01-01)

Association Between the Microsatellite Instability Status and the Efficacy of Postoperative Adjuvant Chemoradiotherapy in Patients With Gastric Cancer
by: Dongfang Dai, et al.
Published: (2020-01-01)

Postoperative chemoradiotherapy combined with epirubicin-based triplet chemotherapy for locally advanced adenocarcinoma of the stomach or gastroesophageal junction.
by: Guichao Li, et al.
Published: (2013-01-01)

Mediastinal lymphadenectomy influences postoperative immune response after lung cancer surgery
by: Tomasz SZCZESNY, et al.
Published: (2008-10-01)

Time-related improvement of survival in resectable gastric cancer: the role of Japanese-style gastrectomy with D2 lymphadenectomy and adjuvant chemotherapy
by: Vidal Oscar, et al.
Published: (2006-08-01)

Individualized prediction of survival benefits from perioperative chemoradiotherapy for patients with resectable gastric cancer
by: Keying Che, et al.
Published: (2020-10-01)

Postoperative Chemotherapy for Medulloblastoma
by: J Gordon Millichap
Published: (2005-03-01)

CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer
by: Astrid E. Slagter, et al.
Published: (2018-09-01)

Patterns of recurrence after curative D2 resection for gastric cancer: Implications for postoperative radiotherapy
by: Jing Xu, et al.
Published: (2020-07-01)

Perineural Invasion and Postoperative Adjuvant Chemotherapy Efficacy in Patients With Gastric Cancer
by: Qing Tao, et al.
Published: (2020-04-01)

Postoperative standard chemoradiotherapy benefits primary glioblastoma patients of all ages
by: Guanzhang Li, et al.
Published: (2020-03-01)

Impact of postoperative major complications on long-term survival after radical resection of gastric cancer
by: Peng Yuan, et al.
Published: (2019-08-01)

Postoperative Concurrent Chemoradiotherapy versus Postoperative Radiotherapy Alone for Larynx Squamous Cell Carcinoma Patients with Lymphovascular Invasion: A Propensity Score Matching Study
by: Yu S, et al.
Published: (2020-05-01)

A Case of Noncuratively Resected Gastric Cancer and Postoperative Chemotherapy with S-1 Monotherapy Resulting in Long-Term Survival for Over 8 Years
by: Byoung Jo Suh
Published: (2017-02-01)

Impact of Postoperative Chemoradiotherapy versus Chemotherapy Alone on Recurrence and Survival in Patients with Stage II and III Upper Rectal Cancer: A Propensity Score-Matched Analysis.
by: Changhoon Song, et al.
Published: (2015-01-01)

The role of definitive chemoradiotherapy versus surgery as initial treatments for potentially resectable esophageal carcinoma
by: Ming-Wei Ma, et al.
Published: (2018-08-01)

Impact of Resected Gastric Volume on Postoperative Weight Loss after Laparoscopic Sleeve Gastrectomy
by: Stefano D’Ugo, et al.
Published: (2019-01-01)

Early postoperative imaging after non-bariatric gastric resection: a primer for radiologists
by: Massimo Tonolini, et al.
Published: (2017-06-01)

Comprehensive Complication Index Predicts Cancer-Specific Survival of Patients with Postoperative Complications after Curative Resection of Gastric Cancer
by: Ru-Hong Tu, et al.
Published: (2018-01-01)

Postoperative radiotherapy and tumor recurrence after complete resection of stage II/III thymic tumor: a meta-analysis of cohort studies
by: Ma JT, et al.
Published: (2016-07-01)

Chemoradiotherapy versus surgery followed by postoperative radiotherapy in tonsil cancer: Korean Radiation Oncology Group (KROG) study
by: Sanghyuk Song, et al.
Published: (2017-08-01)

Postoperative Concurrent Chemoradiotherapy Versus Radiotherapy Alone for Advanced Oral Cavity Cancer in the Era of Modern Radiation Techniques
by: Tae Hyung Kim, et al.
Published: (2021-03-01)

Comparing the benefits of chemoradiotherapy and chemotherapy for resectable stage III A/N2 non-small cell lung cancer: a meta-analysis
by: Yuqiao Chen, et al.
Published: (2018-01-01)

Comparison of Postoperative Adjuvant Chemotherapy and Concurrent Chemoradiotherapy for FIGO2018 Stage IIIC1 Cervical Cancer: A Retrospective Study
by: Masahiro Kagabu, et al.
Published: (2021-05-01)

Chemoradiotherapy versus chemotherapy as adjuvant treatment for localized gastric cancer: a propensity score-matched analysis
by: Daniel M. Girardi, et al.
Published: (2018-04-01)

Efficacy of Postoperative FOLFOX Versus XELOX Chemotherapy for Gastric Cancer and Prognostic Value of Platelet–Lymphocyte Ratio in Patients Receiving XELOX
by: Xin Yin, et al.
Published: (2020-12-01)